Viewing nowRosuvastatin Tablets 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea United Pharm Co., Ltd.

MFDS item code 201001026 · Approved 2010.01.29 · Insurance code 644307830
Treats dyslipidemia, slows the progression of atherosclerosis, and prevents cardiovascular disease
This medication helps patients with primary and familial hypercholesterolemia and mixed dyslipidemia who cannot control their condition with diet and exercise alone. It is particularly used to lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, slowing the progression of atherosclerosis. It can also be used as a dietary supplement for children aged 10 to 17 years with elevated LDL cholesterol levels and increased cardiovascular disease risk. It can help patients with primary dysbetalipoproteinemia. In men and women over middle age with high cardiovascular disease risk, it is effective in reducing the risk of stroke, myocardial infarction, and vascular revascularization. This medication is used for cholesterol control and improving cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The starting dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 mg daily. 3. Elderly patients : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on administering doses greater than 20 mg to pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, it should not be given to patients with an allergy to its components, severe liver dysfunction, muscle diseases, and those on specific medications. It is also not safe for pregnant or breastfeeding women, and it is advised for fertile women who do not have proper contraception. Furthermore, high doses are contraindicated in patients at high risk for muscle diseases. It is important to periodically check liver function tests and muscle conditions when using this medication. Those who drink large amounts of alcohol or have a history of liver disease should be particularly cautious, and thyroid function should be treated beforehand if hypothyroidism is present. If symptoms such as muscle pain or weakness occur, inform a physician immediately and get tested. This medication may increase blood glucose levels in some patients, so individuals at risk of diabetes should manage their blood glucose levels properly. This medication can interact with various other drugs, so if you are taking other medications, it is essential to consult your doctor or pharmacist. Special caution should be taken when used alongside certain antivirals, immunosuppressants, antibiotics, and fibrate drugs. It should not be used during pregnancy, and women who plan to become pregnant or may become pregnant must use proper contraception. In case of overdose, there is no specific antidote, so visit a medical institution immediately for symptomatic treatment, and liver function and muscle enzyme levels should be monitored. Finally, the effect of this medication on driving or operating machinery is unclear, but caution is advised as dizziness may occur.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced eczema, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1°C and 30°C.
Pink, convex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea United Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.